BR112014014036A2 - composição antibacteriana de timol e totarol - Google Patents

composição antibacteriana de timol e totarol

Info

Publication number
BR112014014036A2
BR112014014036A2 BR112014014036A BR112014014036A BR112014014036A2 BR 112014014036 A2 BR112014014036 A2 BR 112014014036A2 BR 112014014036 A BR112014014036 A BR 112014014036A BR 112014014036 A BR112014014036 A BR 112014014036A BR 112014014036 A2 BR112014014036 A2 BR 112014014036A2
Authority
BR
Brazil
Prior art keywords
totarol
thymol
antibacterial composition
abstract
antibacterial
Prior art date
Application number
BR112014014036A
Other languages
English (en)
Other versions
BR112014014036B1 (pt
Inventor
Mattai Jairajh
Masters James
Du-Thumm Laurence
Hourigan Regina
Gafur Rehana
Pilch Shira
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BR112014014036A2 publication Critical patent/BR112014014036A2/pt
Publication of BR112014014036B1 publication Critical patent/BR112014014036B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

resumo composição antibacteriana de timol e totarol uma composição antibacteriana compreendendo timol e totarol. esta combinação provê um efeito sinérgico contra bactérias gram negativa e gram positiva.
BR112014014036-7A 2011-12-15 2011-12-15 Composição antibacteriana de timol e totarol BR112014014036B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/065024 WO2013089721A1 (en) 2011-12-15 2011-12-15 Thymol and totarol antibacterial composition

Publications (2)

Publication Number Publication Date
BR112014014036A2 true BR112014014036A2 (pt) 2017-06-13
BR112014014036B1 BR112014014036B1 (pt) 2018-02-14

Family

ID=45524939

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014036-7A BR112014014036B1 (pt) 2011-12-15 2011-12-15 Composição antibacteriana de timol e totarol

Country Status (11)

Country Link
US (1) US9832994B2 (pt)
EP (1) EP2790504B1 (pt)
KR (1) KR20140104011A (pt)
CN (1) CN103974617B (pt)
AU (1) AU2011383313B2 (pt)
BR (1) BR112014014036B1 (pt)
CA (1) CA2859519C (pt)
MX (1) MX354741B (pt)
PH (1) PH12014501239A1 (pt)
RU (1) RU2563208C1 (pt)
WO (1) WO2013089721A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013108870A1 (de) * 2013-08-16 2015-02-19 Aimecs Gmbh Mittel zur Reinigung und zum Schutz von technischen Oberflächen
CN104027260A (zh) * 2014-06-20 2014-09-10 广州薇美姿个人护理用品有限公司 一种含有桃柘酚的口腔护理用品
CN104664551A (zh) * 2015-01-19 2015-06-03 吉林大学 一种抑制金黄色葡萄球菌外毒素分泌的抑制剂
KR101706284B1 (ko) 2015-03-10 2017-03-15 주식회사 불스원 훈증형 항균 조성물 및 이를 포함하는 훈증기
PL236429B1 (pl) * 2017-07-06 2021-01-11 Emergopharm Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa Zastosowanie totarolu do wytwarzania preparatu do leczenia bakteryjnego zakażenia pochwy i kompozycja farmaceutyczna do zastosowania w leczeniu stanów zapalnych pochwy o podłożu bakteryjnym

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002451B (el) * 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
CN1249929A (zh) * 1998-10-07 2000-04-12 逻辑技术国际公司 抗菌组合物
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
NZ530834A (en) * 2004-01-28 2007-06-29 Owen John Catchpole Near-critical extraction of totarol and/or a product containing totarol
WO2006134160A2 (en) 2005-06-17 2006-12-21 Symrise Gmbh & Co. Kg Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
US20070258996A1 (en) 2005-12-23 2007-11-08 The Sterilex Corporation Antimicrobial compositions
US20080194518A1 (en) 2005-12-23 2008-08-14 MOOKERJEE Pradip Antimicrobial Compositions
US20090312279A1 (en) 2005-12-23 2009-12-17 Sterilex Technologies, Llc Antimicrobial compositions
US20090324517A1 (en) * 2008-06-30 2009-12-31 Dan Kline Halitosis treatment
GB0813323D0 (en) 2008-07-21 2008-08-27 Campbell Donald Antimicrobial compositions and methods
MX2011004155A (es) * 2008-10-20 2011-05-23 Unilever Nv Una composicion antimicrobiana.
GB2471135A (en) 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
JP5471335B2 (ja) * 2009-11-17 2014-04-16 ライオン株式会社 口腔バイオフィルム殺菌剤

Also Published As

Publication number Publication date
AU2011383313A1 (en) 2014-06-19
AU2011383313B2 (en) 2014-07-31
CA2859519C (en) 2016-08-16
EP2790504A1 (en) 2014-10-22
BR112014014036B1 (pt) 2018-02-14
CN103974617B (zh) 2015-11-25
CN103974617A (zh) 2014-08-06
RU2563208C1 (ru) 2015-09-20
US9832994B2 (en) 2017-12-05
PH12014501239A1 (en) 2014-09-08
WO2013089721A1 (en) 2013-06-20
CA2859519A1 (en) 2013-06-20
EP2790504B1 (en) 2016-03-09
US20140314689A1 (en) 2014-10-23
MX2014007133A (es) 2014-09-04
KR20140104011A (ko) 2014-08-27
MX354741B (es) 2018-03-16

Similar Documents

Publication Publication Date Title
IN2015DN01198A (pt)
PH12016501512A1 (en) Treatment for resistant acne
MX367109B (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
CR20150224A (es) Compuestos de cefem 2-sustituidos
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
IN2014MN02437A (pt)
CL2012003385A1 (es) Tratamiento para la incontinencia.
CL2011000939A1 (es) Compuestos derivados de cefalosporinas sustituidas por un grupo catecol, con actividad antimicrobiana contra bacterias gram negativo que producen betalactamasa; composicion farmaceutica que los comprende; uso en el tratamiento de enfermedades infecciosas.
BR112014000665A2 (pt) composto, uso do mesmo, composição farmacêutica, agente antimicrobiano, e, método para previnir ou tratar uma infecção bacteriana
EP2536406A4 (en) BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, COMPRISING THE TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
UY36448A (es) COMPUESTOS DE ISOXAZOL DE ÁCIDO HIDROXÁMICO COMO INHIBIDORES DE LpxC
BR112013002685A2 (pt) composições alimentícias para animais de estimação apresentando atividade antimicrobiana
ZA201404239B (en) Thymol and totarol antibacterial composition
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
GB2548277A (en) Antibiofilm compositions
BR112014014036A2 (pt) composição antibacteriana de timol e totarol
EP2995200A4 (en) Sterilization composition with synergism
BR112013027403A2 (pt) composições que compreendem uma antimetabólito de glicose e selênio
MX2011011406A (es) Combinacion sinergica de flumetsulam o diclosulam con piritiona de zinc.
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
AU2011365688A8 (en) Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of Paenibacillus elgii ourofinensis extract
BR112014013609A2 (pt) composição antimicrobiana sólida, método da desinfecção de uma superfície e utilização de uma composição
BR112014005788A2 (pt) variante de antitripsina alfa-1, método de preparação da mesma e aplicação da mesma
BR112014013613A2 (pt) composição antimicrobiana, método de desinfecção de uma superfície e uso de uma composição
BR112017012550A2 (pt) composição antibacteriana, compreendendo um acetal ou um éter de hexitano de cadeia alquila longa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 8/34 (2006.01), A61Q 17/00 (2006.01), A61Q 11

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]